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Background: Governments require high-quality scientific evidence to prioritize resource allocation and the cost-of-
illness (COI) methodology is one technique used to estimate the economic burden of a disease. However, variable
cost inventories make it difficult to interpret and compare costs across multiple studies.
Methods: A scoping review was conducted to identify the component costs and the respective data sources used
for estimating the cost of foodborne illnesses in a population. This review was accomplished by: (1) identifying the
research question and relevant literature, (2) selecting the literature, (3) charting, collating, and summarizing the
results. All pertinent data were extracted at the level of detail reported in a study, and the component cost and
source data were subsequently grouped into themes.
Results: Eighty-four studies were identified that described the cost of foodborne illness in humans. Most studies
(80%) were published in the last two decades (1992–2012) in North America and Europe. The 10 most frequently
estimated costs were due to illnesses caused by bacterial foodborne pathogens, with non-typhoidal Salmonella spp.
being the most commonly studied. Forty studies described both individual (direct and indirect) and societal level
costs. The direct individual level component costs most often included were hospital services, physician personnel,
and drug costs. The most commonly reported indirect individual level component cost was productivity losses due
to sick leave from work. Prior estimates published in the literature were the most commonly used source of
component cost data. Data sources were not provided or specifically linked to component costs in several studies.
Conclusions: The results illustrated a highly variable depth and breadth of individual and societal level component
costs, and a wide range of data sources being used. This scoping review can be used as evidence that there is a
lack of standardization in cost inventories in the cost of foodborne illness literature, and to promote greater
transparency and detail of data source reporting. By conforming to a more standardized cost inventory, and by
reporting data sources in more detail, there will be an increase in cost of foodborne illness research that can be
interpreted and compared in a meaningful way.
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Foodborne illnesses are an important public health problem
worldwide [1]. The World Health Organization (WHO)
has created an initiative to estimate the global burden
of foodborne illnesses, and they have stated that the
achievement of certain Millennium Development Goals
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unless otherwise stated.[2,3]. However, governments have finite resources with
which to address the health of their populations, and thus
require high-quality scientific evidence to prioritize resource
allocation. Accurate burden of illness estimates are useful
for decision makers seeking to allocate resources to ad-
dress the issues caused by foodborne pathogens [4,5]. The
cost-of-illness (COI) methodology is one technique used
to estimate the economic burden of a disease [6]. How-
ever, there is concern in the scientific literature that COI
estimates are limited in usefulness, due to variability in
their execution (e.g., varying cost inventories and study
methodologies), and a lack of transparency and detailral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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cern are the differing cost inventories being used when es-
timating the cost of foodborne illnesses [7-10].
The COI approach traces the flow of resources associ-
ated with adverse health outcomes through the quantifi-
cation of measurable individual and societal level costs
[7,11,12]. Costs at the individual level are divided into
direct and indirect costs. Direct costs represent the value
of goods, services, and other resources consumed in pro-
viding care due to an illness [13]. These include medical
care expenditures associated with the diagnosis, treat-
ment, and management of a disease in an individual. In-
direct costs represent productivity losses due to illness
or death and intangible costs such as pain and suffering.
Costs associated with overhead activities that are shared
amongst individuals and expenditures incurred in the
process of seeking care are also indirect costs. Operational
expenditures for healthcare facilities and personal trans-
portation costs are examples of indirect costs [14]. Costs
incurred at the population level are deemed societal costs
[8,9,12], which are costs that cannot be completely attrib-
uted to an individual’s illness but can be incurred when a
person or a group of people become ill [15]. Societal costs
primarily include expenditures incurred by industry and
government [16]. Component costs are the specific costs
that make up the above categories, and all of the costs in-
cluded in a COI estimate comprise the cost inventory for
that particular study [17].
Many studies employing a COI methodology have
demonstrated that foodborne illnesses generate a consid-
erable disease burden and economic loss [11]. According
to the United States Department of Agriculture (USDA),
foodborne illness costs the United States economy be-
tween $10-83 billion United States dollars (USD) per year
[18]. In Australia and New Zealand, the cost of food-
borne illness has been estimated at $1.289 billion and
$86 million USD respectively per year [14,19]. In Europe,
the annual cost of foodborne illness was estimated to be
$171 million USD in Sweden [6] and $2 million USD in
Croatia [20]. Many estimates for specific foodborne
pathogens, or groups of pathogens, have been published
[4,21,22]. Although economic estimates for foodborne ill-
ness have not been completed in Canada in the past
20 years [23], it has been recently estimated that 4 million
episodes of domestically acquired foodborne illness occur
annually in Canada [24].
Research has indicated that COI studies employ varied
methodological approaches, and that there is little
consistency in the cost inventories used in the COI lit-
erature [7-10]. This is an issue when interpreting and
designing new COI studies, and also when comparing
existing estimates for the same illnesses. When designing
a study, it is difficult to determine which types of costs to
include (e.g., direct, indirect, societal), which componentcosts in those categories to include (e.g., treatment costs,
productivity losses, industry costs), and the level of detail
by which costs should be estimated (e.g., which types of
treatment or industry costs to include). It is also challen-
ging to interpret or compare estimates without fully under-
standing which component costs were included in a study.
Another concern is the lack of transparency when describ-
ing how specific component costs were estimated and the
data sources being used for such estimates [8,25,26].
To investigate the reporting of component costs in the
cost of foodborne illness literature, along with their rele-
vant data sources, a review of the evidence is needed.
The scoping study, or scoping review, is one approach
used to survey the literature and aims to map the key
concepts underpinning a research area [27]. The frame-
work for conducting a scoping review emphasizes that
the methods used throughout all stages of the process
are conducted in a rigorous and transparent way. The
process should be documented in sufficient detail to en-
able the review to be replicated by others, and this explicit
approach increases the reliability of the findings. Unlike a
systematic review, a scoping study does not often lead to
the statistical pooling of quantitative evidence from vari-
ous studies, as is often done in meta-analyses of system-
atic review data. While a scoping study uses an analytical
framework or thematic construction to present the evi-
dence, there is no attempt made to present the weight or
quality of evidence in relation to particular policies or in-
terventions [27,28].
This study employed a scoping review methodology to
address the research question: “What are the component
costs and the respective data sources being used for esti-
mating the cost of foodborne illnesses in a population?”
Methods
Scoping review methodology
The scoping review framework published by Arksey and
O’Malley in 2005 [27] includes 5 required stages which
were followed in the present study. Many other scoping
reviews have subsequently used this framework as a
guideline [29].
Identifying the research question
The research team, consisting of academic and govern-
ment researchers with expertise in the areas of food-
borne illness and public health, jointly determined how
to synthesize the cost of foodborne illness literature
through a series of in-person meetings. The government
researchers also contributed as potential end-users of
the information obtained from a review in this area. The
goals were to identify the different component costs that
have been included when determining the cost of food-
borne illnesses, and to identify the data sources used to
calculate these estimates.
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Two comprehensive electronic databases were chosen
for the literature search. The MEDLINE (PubMed) data-
base was used to identify studies from the human med-
ical literature whereas studies from the animal health
literature were located in the AGRICOLA database. Prior
to the searches, 15 studies were identified by the research
team as being highly relevant to a review in this area.
The identification of these studies following relevance
screening was used to verify the comprehensiveness of
the search. Broad keyword searches were performed be-
tween October 27th and November 1st 2012 to identify
studies that addressed the COI of any infectious disease,
including foodborne illnesses (Table 1). Search terms
were selected by extensive review of the terminologyTable 1 Scoping review keyword search strategy to
identify cost-of-illness studies for infectious diseasesa
Foodborne keywords Communicable keywords Cost keywords
Foodborne illness Communicable Cost
Foodborne illnesses Communicable disease Costs
Food-borne illness Communicable diseases Cost-of-illness
Food-borne illnesses Communicable illness Cost of illness
Foodborne disease Communicable illnesses Cost-of-illnesses
Foodborne diseases Infectious Cost of illnesses
Food-borne disease Infectious disease Costs-of-illness
Food-borne diseases Infectious diseases Costs of illness
Foodborne infection Infectious illness Costs-of-illnesses
Foodborne infections Infectious illnesses Costs of illnesses
Food-borne infection Transmissible Coi
Food-borne infections Transmissible disease Direct Costs
Food poison Transmissible diseases Direct Cost
Food poisoning Transmissible illness Indirect Costs














aKeywords in each column (Foodborne, Communicable, Cost) were combined
with the Boolean operator ‘OR’ and then each of the combined categories
were further combined with the operator ‘AND’ in the database searches.used in the titles and abstracts of the 15 studies of known
relevance. No restrictions were placed on date, country,
or language of publication during the searches. A broad
search approach (i.e., using infectious disease keywords)
was used initially. This allowed for later refinement of
the data extraction process to address the specific re-
search question for the study reported herein. The ‘peer-
reviewed’ filter was unchecked in the AGRICOLA search.
All of the search results were imported into RefWorks
Reference Management Software (ProQuest LLP, 2012),
and duplicate citations were removed using the close and
exact-match functions.
Study selection
Prior to screening, reviewers were provided with instruc-
tional documents that outlined the objectives of the re-
view and how the results would be presented (i.e., using
empty shell tables). The 15 studies of known relevance
were also provided to the reviewers. Subsequently, titles
and abstracts of 250 test studies were independently
screened by two reviewers, and also by a member of the
research team. The 250 test studies were selected at ran-
dom from those identified by the literature searches. Any
disagreements during the testing stage were discussed
by all 3 of the reviewers, and differences were resolved
by consensus. Two levels of relevance screening were per-
formed. Each level was based on reviews of the title and
abstract only, with the second level of screening also serv-
ing as a categorization step. Both levels of screening were
performed independently by two reviewers. The first
round of screening, which included all citations from the
database searches, identified studies that described the
COI of any infectious (communicable) disease, including
foodborne illnesses, while excluding cost-effectiveness
studies for specific interventions. A standardized rele-
vance screening tool was created in Microsoft Excel
(Version 2007). A Cohen’s kappa coefficient was cal-
culated to establish a minimum level of agreement be-
tween each reviewer following the first relevance screening
round. If the level of agreement was found to be poor
(i.e., raised concerns among the reviewers), a third re-
viewer would have been used and the first round of rele-
vance screening would be repeated.
Studies selected after the first round of screening under-
went a second level of screening, whereby each of the in-
fectious and foodborne disease COI studies were further
classified into those that described the cost of foodborne
illnesses in humans, foodborne illnesses in animals, infec-
tious diseases in humans, infectious diseases in animals, a
combination of any of these categories, none of these
categories (the study did not describe the cost of an infec-
tious or foodborne illness), and as studies in which rele-
vance could not be determined using the title and abstract.
Following the second level of relevance screening, the
Table 2 Descriptive information of the 84 cost of
foodborne illness studies published between 1972 and
2012 identified from a scoping review

















2002 - 2012 36
1992 - 2001 31
1982 - 1991 15






1. Non-typhoidal Salmonella spp. 51
2. Shiga-toxin producing Escherichia coli 34
3. Campylobacter spp. 27
4. Vibrio spp. 19
5. Staphylococcus aureus 17
6. Listeria monocytogenes 16
7. Clostridium perfringens 12
8. Salmonella typhi 12
9. Clostridium botulinum 11








aNon-English study languages: Swedish (4), German (3), Italian (1), Danish (1),
Russian (1).
bNon-relevant studies: Did not describe component costs (i.e., studies that
were identified as relevant through both levels of screening, but did not
provide the data of interest).
cToxoplasma gondii (10), Cyptosporidium spp. (7), Cyclospora cayetanensis (5),
Trichinella spp. (3), Giardia lamblia (3), Taenia spp. (1).
dNorovirus (9), Hepatitis A (6), Rotavirus (6), Astrovirus (4), Saprovirus (2),
Adenovirus (1).
eYersinia enterocolitica (8), Bacillus cereus (6), Brucella spp. (4), Streptococcus
spp. (4), Mycobacterium bovis (1), Plesiomonas spp. (1).
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only, and all other categories of studies were excluded. Re-
sults from each level of screening were compared between
reviewers and conflicts resolved by consensus through an
open discussion.
Charting the data
Citations describing the cost of foodborne illnesses in
humans (with or without other infectious illnesses) and
citations where relevance could not be determined using
the title and abstract were retrieved in full text. A stan-
dardized data-charting form was created in Microsoft
Excel (Version 2007). Training for data extraction was
performed using instruction forms and 7 full text stud-
ies. Data extraction was conducted by two independent
researchers, and the completed forms were compared
for comprehensiveness. Therefore, if one researcher ex-
tracted data that the other had omitted, the study was
re-examined by both reviewers, and differences in ex-
tracted data were resolved by consensus.
The data-charting form had two sections, the first for
gathering descriptive information on the relevant studies
(Table 2) and the second for gathering the data of inter-
est: the individual and societal level component costs in-
cluded in the studies and the data sources for those
estimations (Tables 3 and 4). Descriptive data included in-
formation on the title of the study, whether it was avail-
able in English, whether it directly estimated COI due to
one or more foodborne pathogens, and whether it de-
scribed the component costs for the estimate. The year of
publication, country of publication, and a list of foodborne
pathogens included in the study were also collected. All
component cost data were extracted at the level of detail
reported in each study rather than using pre-determined
categories for data extraction. Therefore, the specificity
and detail in the extracted data were representative of the
level of detail reported in the paper. The source of data
for each component cost was also collected, detailing
whether the data for the estimation came directly from a:
survey, pre-existing databases, hospital records, an online
calculator (e.g., Economic Research Service of the United
States Department of Agriculture’s foodborne illness cost
calculator) [30], the literature, population statistics, census
data, outbreak data, or expert opinion.
Collating, summarizing, and reporting the results
The primary goal of this step was to refine the informa-
tion extracted from the studies into manageable group-
ings, or themes. Two researchers independently grouped
the component cost and source data extracted from each
paper into themes and differences were resolved by con-
sensus throughout the process. The grouped information
was summarized in categories of individual level (direct
and indirect) and societal level component costs.
Table 3 Individual level component costs and data sources from 84 cost of foodborne illness studies published
between 1972 and 2012 identified from a scoping review
Component costs Na Data sourcesb
Direct costs H D L OC S O C P E M N/P N/A
Medical costs 16 1 3 2 - - 3 - - - - 2 5
Treatment costs 14 4 2 3 - 1 - - - - 3 - 1
Drug costs 29 3 3 6 1 3 2 1 - - 4 3 3
Prescription 18 3 3 1 - 6 - 1 - - 1 1 2
Over-the-counter 6 - 1 1 - 4 - - - - - - -
Non-personal transportation (ambulance) 12 1 1 3 1 - - - 1 2 1 - 2
Rehabilitation 10 - 1 3 1 - 1 1 - - 2 - 1
Materials (disposable/non-disposable) 7 1 2 - - 1 1 1 - - - 1 -
Home visits 5 - - - - - - - - - 1 3 1
Rehydration treatment 2 1 - - - 1 - - - - - - -
Palliative care 1 - 1 - - - - - - - - - -
Laboratory costs 20 5 3 2 1 2 1 - - 1 2 1 2
Pathogen diagnosis and analysis 15 3 2 1 - 2 3 - - - 3 - 1
Ancillary diagnostics 10 3 2 1 1 - 2 - - - - - 1
Laboratory sampling 7 1 1 2 - 3 - - - - - - -
Personnel costs 7 2 3 - - 2 - - - - - - -
Physician 31 1 6 5 1 3 3 1 - 1 6 2 2
General practitioner physician 17 2 5 4 - 3 - - - - 3 - -
Non-physician 2 - - - - 1 - - - - 1 - -
Nurses 4 1 - 1 - - 1 - - - 1 - -
Laboratory technician 3 1 - - - - 2 - - - - - -
Consultants 7 - 1 2 - 1 2 - - - 1 - -
Specialists 5 1 1 - - - - - - - 1 1 1
Hospital services costs 46 5 6 11 1 2 5 1 - 1 7 3 4
Emergency room 14 4 3 1 - 1 - - - - 3 - 2
Intensive care unit 5 1 1 - - - - 1 - - 2 - -
Surgical services 3 - 1 - - - - - - - 1 - 1
Dialysis 2 1 1 - - - - - - - - - -
Community services (out-patient) costs 11 - 3 1 - - - - - - 3 1 3
Long-term care services costs 4 - 2 - - - - - - - - 1 1
Indirect costs
Productivity losses 30 - 2 6 1 4 2 - - - 3 4 8
Due to sick leave from work (patient) 42 1 6 7 1 10 3 1 1 - 4 1 6
Due to caring for others (caregiver) 19 - 5 3 - 6 2 - - - 3 - -
Due to care of sick children 11 - 2 1 1 1 1 - - - 1 2 2
Lost leisure time 14 - 3 6 1 - 1 - - - 1 - 2
Due to long-term or permanent disability 8 - 1 2 - - 2 - - - 2 - 1
Patient transportation (non-ambulance) costs 20 - 2 6 - 5 1 - 1 - 1 2 2
For visitors and relatives 6 - - 1 - 1 1 - - - 1 - 2
Parking fees 1 - - - - 1 - - - - - - -
Additional costs - - - - - - - - - - - - -
Value-of-life lost 29 - 1 15 1 1 1 - - - 3 2 5
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Table 3 Individual level component costs and data sources from 84 cost of foodborne illness studies published
between 1972 and 2012 identified from a scoping review (Continued)
Pain and suffering 21 - - 8 2 2 1 - - - 2 2 4
Risk aversion behaviours 9 2 2 - 1 2 - - - - - - 2
Facility (operational) costs 9 1 2 2 1 - - - - - 2 1 -
Non-medical materials 7 - - 1 1 3 - - - - - 1 1
Totals 49 84 108 17 72 41 8 3 5 69 34 68
aCounts represent the number of studies reporting each component cost category at the specified level of detail. Therefore, a study that is counted as including a
higher-level category (e.g., treatment costs) cannot contribute a count to a lower-level category (e.g., drug costs) within the same grouping, and vice versa.
bD: Database, L: Literature, OC: Online calculator S: Survey, O: Outbreak data, C: Census, P: Population statistics, E: Expert opinion, M: Multiple, N/P: Not provided,
N/A: Not applicable.
McLinden et al. BMC Public Health 2014, 14:509 Page 6 of 12
http://www.biomedcentral.com/1471-2458/14/509Tables 3 and 4 display the categories of direct and in-
direct costs included at the individual level and the data
sources used for each component cost category. The cat-
egories were created based on the level of detail pro-
vided in the study and thus, some categories represent
more detailed sub-categories. Therefore, a study which
included ‘medical costs’ did not explicitly describe any
other direct costs included in their COI estimate. Simi-
larly, all of the studies that were categorized as including
a broad component cost category (e.g., treatment costs,
personnel costs, hospital service costs) were not counted
towards including a more specific component in those
categories. However, studies may have ultimately in-
cluded these more specific costs in their estimates, but
the components were unknown due to a superficial level
of reporting detail.
Data sources were grouped as follows: if the authors of
a study stated that the literature was used for an esti-
mate, the source of data was described as ‘literature’.
The original source of data in the cited literature may
have been one of the other categories (e.g., a survey or
pre-existing databases), however, the cited literature was
not obtained to determine the actual data source. The
same principle applied for databases, population statis-
tics, outbreak data, or census data that may have been
created using information from other data sources. This
resulted in potential overlapping between data source cat-
egories, as only the immediate source of data was identi-
fied in the present study. Cost calculators often provide
component cost estimates that have been amalgamated
from a range of data sources, and are tools that can be
used when estimating costs [31]. Sources of component
cost data could also be described as not provided (N/P),
not applicable (N/A), or as ‘multiple’, meaning numerous
component costs and data sources were described without
specifying which data sources were used for a particular
component cost estimate.
Results
Following duplicate removal, the MEDLINE (PubMed)
and AGRICOLA database searches yielded 7633 refer-
ences to be screened for relevance (Figure 1). Of these,7394 were excluded as they did not describe the COI of
any infectious or foodborne illnesses. All of the 15 studies
identified by the research team as being highly relevant to
a review in this area prior to the literature searches were
identified by the employed search strategy. The Cohen’s
kappa coefficient was 0.89 for the first relevance screen-
ing round, indicating substantial agreement between
the two reviewers [32]. In the second round of screening,
the remaining 239 references were classified into 1 of 7
categories based on the type of COI that was estimated
(e.g., cost of foodborne illness in humans). Classifications
for studies that fell into multiple categories, none of the
categories, or studies where the relevance could not be de-
termined were also used.
Following the second round of relevance screening,
references that focused on foodborne illness in humans,
a combination of categories, and those where relevance
could not be determined from the title and abstract were
selected (n = 108). Ten non-English references were identi-
fied and excluded, as were an additional 14 studies that
did not provide any information on component costs.
Therefore, 84 studies ultimately underwent data ex-
traction. These studies described studies that directly esti-
mated the cost of foodborne illnesses and studies that
described component costs but did not provide an estimate.
The majority of the studies (n = 74, 88%) calculated
the cost of a foodborne illness (or a group of foodborne
illnesses) and described the component costs included in
the estimates (Table 2). Ten studies described compo-
nent costs, but did not directly calculate the cost of a
foodborne illness. Papers in this latter category were
foodborne illness prioritization studies, burden of food-
borne illness reviews, and conceptual studies such as
cost of foodborne illness frameworks. Although the ob-
jective of this group of studies was not to calculate the
cost of a foodborne illness, they did describe component
costs and were therefore included. Data source identifi-
cation was not applicable (N/A) for these ten studies. Of
the 74 COI studies, 36 (49%) estimated the cost of a sin-
gle foodborne pathogen while 38 (51%) examined mul-
tiple pathogens. Among all included studies (n = 84), most
(80%) were published in the last two decades (1992–2012)
Table 4 Societal level component costs and data sources from 84 cost of foodborne illness studies published between
1972 and 2012 identified from a scoping review
Component costs Na Data sourcesb
D L OC S O C P E M N/P N/A
Industry costs 10 3 3 1 1 - - - - - - 2
Losses to businesses 13 1 2 - 1 1 - - - 2 2 4
Reduced product demand 7 - 3 - 1 - - - - 1 - 2
Advertising to regain customer trust 6 1 2 1 - - - - - - - 2
Losses to food service establishments 5 - 2 - - 1 - - - 1 - 1
Product spoilage 4 - 1 - - 1 - - - - - 2
Product recall 11 - 3 1 2 - - 1 - 1 - 3
Farm-related costs 3 - 2 - - - - - - - - 1
Herd slaughter 4 - 1 1 - - - - 1 - - 1
Farmers compensation 2 2 - - - - - - - - - -
Increased time to market 2 - 1 1 - - - - - - - -
Adjusted manufacturing procedures 9 - 3 - 2 1 - - - 1 - 2
Plant closure and bankruptcy 6 - 2 - 1 1 - - - 1 - 1
Equipment 5 1 2 - - - - - 1 1 - -
Public health costs 5 2 - - 1 - - - - - - 2
Outbreak investigation costs 15 - 5 - 4 2 - - - - - 4
Laboratory testing 10 1 3 - 1 2 - - - 1 - 2
Personnel 7 - - - 1 4 - - - 1 - 1
On-site treatment 3 - 2 - - - - - - - - 1
Clean up (including food destruction) 3 - 3 - - - - - - - - -
Consumables 3 - - - 1 2 - - - - - -
Administration 2 1 - - - 1 - - - - - -
Source identification 2 - - - 1 1 - - - - - -
Make-shift food services 2 - - - - 2 - - - - - -
Travel 2 - - - - 1 - 1 - - - -
Prevention 6 2 - - - - - - 1 - - 3
Surveillance (including database creation) 11 2 5 1 1 - - - - 1 - 1
Educational campaigns 7 - 2 1 - - - - - 1 2 1
Research 6 2 1 - - 1 - - - 1 - 1
Vaccination programs 2 - 1 - - - - - - - - 1
Legal costs 6 1 1 - 1 1 - - - 1 - 1
Product liability suits 5 - 2 - 1 1 - - - - - 1
Insurance-related 4 - 2 - - 1 - - - 1 - -
Victim (individual) settlements 3 - - - - - - - - - - 3
Class action (group) settlements 1 - - - - - - - - - - 1
Out-of-court settlements 1 - - - - - - - - 1 - -
Prosecution costs from public funds 1 - - - - - - - - - - 1
Jail sentences 1 - - - - - - - - 1 - -
Government and regulatory costs 7 2 - - 1 1 - - 1 1 - 1
Regulatory fines and enforcement 6 - 2 1 - - - 1 - 1 - 1
Local authority investigations 5 1 1 - 2 - - - - - - 1
Public inquiry 1 - - - - - - 1 - - - -
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Table 4 Societal level component costs and data sources from 84 cost of foodborne illness studies published between
1972 and 2012 identified from a scoping review (Continued)
Policy implementation and monitoring 1 - - - - - - - - - - 1
Totals 22 57 8 23 25 0 4 4 19 4 49
aCounts represent the number of studies reporting each component cost category at the specified level of detail. Therefore, a study that is counted as including a
higher-level category (e.g., industry costs) cannot contribute a count to a lower-level category (e.g., product recall) within the same grouping, and vice versa.
bD: Database, L: Literature, OC: Online calculator S: Survey, O: Outbreak data, C: Census, P: Population statistics, E: Expert opinion, M: Multiple, N/P: Not provided,
N/A: Not applicable.
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frequently estimated costs were those due to illnesses
caused by bacterial foodborne pathogens, with non-
typhoidal Salmonella spp. (n = 51, i.e., COI for this patho-
gen was reported in 51 of 74 studies estimating costs),
shiga-toxin producing E. coli (n = 34), and Campylobacter
spp. (n = 27) being the most commonly studied. Add-
itional bacterial foodborne pathogens were included in
multiple studies (refer to footnotes of Table 2), as well as
foodborne viruses, protozoa, and parasites.
Among the 84 studies included in the review, 40 (48%)
studies described both individual (direct and indirect) and
societal level costs. Twenty-seven (32%) studies describedMEDLINE via PubMed


















































Figure 1 Scoping review flow chart. aStudies were excluded as they did
non-English references were excluded (4 Swedish, 3 German, 1 Italian, 1 Da
any information on component costs.individual level costs only, while 10 (12%) studies de-
scribed direct costs exclusively. Three studies solely exam-
ined the societal costs associated with foodborne illness.
The remaining studies described both societal and direct
individual costs (n = 2) or societal and indirect individual
costs (n = 2).
The direct individual level component costs most often
included were broadly described as hospital services costs
(n = 46) without explicitly describing which hospital ser-
vice costs they estimated (e.g., emergency room costs, in-
tensive care costs, surgical services costs, dialysis costs).
Physician costs, a component of personnel costs, were com-
monly included (n = 31) along with drug costs (n = 29), aAGRICOLA














1. Foodborne illness in 
humans (n = 79)
2. Foodborne illness in 
animals (n = 2)
3. Infectious diseases in 
humans (n = 86)
4. Infectious diseases in 
animals (n = 17)
5. Combination of 
categories (n = 23)
6. None of these categories 
(n = 26)
7. Relevance could not be 
determined by title and










not describe the COI of any infectious or foodborne illnesses. bTen
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these and other costs at a greater depth (e.g., prescription
and over-the-counter costs as a component of drug costs),
and there was substantial variation in the specificity and
detail among studies when describing component costs.
The most commonly reported indirect component cost
was productivity losses due to sick leave from work (n = 42).
A large number of studies included a cost estimate for
‘productivity losses’ without specifically stating which
individual was experiencing the loss of output (e.g., the pa-
tient or caregiver) (n = 30). The value-of-life lost was
estimated in 29 studies while costs broadly described
as ‘personal transportation’ expenses were calculated in
20 studies.
Prior estimates published in the literature were the
most commonly used source of individual level compo-
nent cost data (used 108 times), followed by databases
(84 times) and surveys (72 times). Multiple sources were
listed for component cost estimates on 69 occasions.
These studies included a description of multiple compo-
nent costs and data sources without specifying which
data sources were used for a particular component cost
estimate. No data sources were provided for component
cost estimates 34 times, and data sources were not ap-
plicable for 68 of the component costs. These compo-
nent costs came from the 10 studies that did not directly
estimate a cost of foodborne illness.
The societal level component costs that were most often
included in cost of foodborne illness studies were out-
break investigation costs (a component of public health
costs, n = 15), losses incurred by businesses (a component
of industry cost, n = 13), costs associated with product
recall (a component of industry costs, n = 11), and costs
related to public health surveillance of foodborne illness
(n = 11) (Table 4). Other societal costs included in some
studies were legal costs and government related (regula-
tory) costs.
Similar to the individual costs, prior estimates pub-
lished in the literature were the most commonly used
source of component cost data for societal costs (used
57 times). Outbreak data, surveys, and pre-existing data-
bases were used 25, 23, and 22 times respectively. Multiple
sources were listed for 19 component costs. These studies
described numerous component costs and data sources
without specifying which data sources were used for a par-
ticular component cost estimate. No data sources were
provided for component cost estimates 4 times, and data
sources were not applicable on 49 occasions.
Discussion
This scoping review explored component costs of food-
borne illness and sources of data for the cost estimates.
High variability in terms of the depth and breadth of indi-
vidual and societal level cost components and the datasources being used in the published cost of foodborne ill-
ness literature was observed. Rather than being guided by
a highly specific research question and particular study de-
signs, a scoping review is guided by the broad requirement
of identifying all relevant literature that pertains to the re-
search question [27]. Due to the potential usefulness of
COI studies to inform decision makers, it is important
that COI estimates are derived in a uniform, consistent,
and transparent manner [12,25,26]. To address the issues
of uniformity in cost inventories and transparency in data
source usage, a better understanding of which cost com-
ponents are included and how they are described in the
published cost of foodborne illness literature is critical.
Most studies were based in North America and Europe,
indicating that the results are more applicable to devel-
oped country contexts and may not represent foodborne
illness component costs and data sources in developing
nations. This may be due to a lack of resources to conduct
COI studies or it may be a reflection of other infectious
disease priorities for developing countries. The majority of
the cost of foodborne illness studies identified have been
published in the past two decades (1992–2012), which
is a trend observed in all COI literature [14]. The 10 most
frequently estimated costs were those due to illnesses
caused by bacterial foodborne pathogens. This was ex-
pected as these pathogens are cited as carrying a large bur-
den in terms of the number of illnesses, hospitalizations,
and deaths [17].
The primary results from this study are the reporting
patterns of component costs in the cost of foodborne ill-
ness literature along with the sources of data for each es-
timate. In regards to the breadth of cost inventories,
almost half of the studies (48%) included individual level
costs (direct and indirect) and societal level costs in their
estimates. This indicated that many studies are estimat-
ing a wide spectrum of costs associated with foodborne
illnesses. Fewer studies included societal costs compared
to individual costs. Societal level costs may be more difficult
to calculate, as attributing costs incurred at the population
level due to a particular illness might be more challenging
than estimating a direct or indirect cost associated with an
individual person [33]. Additionally, societal costs may not
be applicable given a study’s perspective (e.g., a study esti-
mating healthcare-related costs may omit societal costs).
In the 84 studies included in the review, there was a high
level of variability in the reporting detail of individual and
societal level component costs. For instance, 16 studies
broadly included ‘medical costs’ in their estimates as the
only individual direct cost, while the remainder of stud-
ies estimating direct costs included more specific compo-
nents of medical costs such as treatment costs, laboratory
costs, personnel costs, hospital service costs, community
services costs, and long-term care services costs. Nu-
merous papers provided even greater detail, with studies
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egories. For example, specific treatment-related compo-
nents such as drug and rehabilitation costs were described
in certain studies. The variability in reporting detail
can also be seen in the indirect individual and societal
level costs, which indicates that although a greater level of
specificity can be achieved when calculating component
costs, certain studies elect to estimate costs more superfi-
cially. This is an issue because it does not allow the end-
user of a COI study to fully understand which types of
costs were included in an overall estimation. In turn, this
makes the economic burden of an illness more difficult to
interpret and understand and reduces the feasibility of
meaningfully comparing two studies for the same disease.
The component costs presented in Tables 3 and 4 were
aggregated from all of the relevant cost of foodborne ill-
ness studies identified during the review. However, certain
costs may only be relevant for a particular pathogen or
chronic sequelae. An example of this would be intensive
care unit (ICU) costs incurred due to shiga-toxin produ-
cing E. coli infections, which may not be as relevant to
other foodborne illnesses. A future study could deter-
mine which costs are pathogen-specific and which are
commonly included across all foodborne illnesses. Add-
itionally, of the 74 COI studies, 36 estimated the cost of
a single foodborne pathogen while 38 examined mul-
tiple pathogens. Further research could determine if the
component cost inclusion and reporting detail differs in
single-versus multiple-pathogen studies, and to explore
the implications of this factor when comparing or com-
bining COI estimates.
A further consideration is the impact of data sources
on a cost of foodborne illness estimate. A wide variety of
data sources were used to estimate component costs of
foodborne illness. Certain data sources may be more
credible than others. For example, it could be argued
that costs estimated by expert opinion are more subjective
than estimates taken from hospital records. Future re-
search could compare specific component cost estimates
for a particular pathogen using varying data sources to de-
termine the impact of using different sources of data. How-
ever, because there was an overlapping of data sources
(e.g., an estimate taken from the literature may have
come from a survey), data source variability may be less
substantial than it appears, as only the immediate source
of data was identified in the present study. Additionally,
when a study reports a data source (e.g., the literature)
without identifying the origin of the information, which
may in fact be another data category (e.g., a survey, hos-
pital records, pre-existing database), it does not allow
the reader to easily evaluate the appropriateness or valid-
ity of the data source for the estimate. Also of concern
is the number of component cost estimates that could
not be linked to a particular source of data. For bothindividual and societal costs, multiple sources were listed
for 88 component costs across 14 different studies. These
studies described numerous component costs and data
sources without specifying which data sources were used
for a particular component cost estimate. Data sources
were not provided for 38 individual and societal level
component costs, meaning that an estimate was included
without any explanation of where it came from or how it
was deduced. These are issues of inadequate reporting
that inhibits repeatability of these estimates.
Proponents of COI research have cited that one of the
major strengths of these studies is the potential to com-
pare one estimate to another [12,25]. In an era where
evidence-informed decision making is at the forefront,
synthesizing the evidence from high quality studies is an
important step in making an informed decision [34].
Numerous studies dating back to 1982 have stressed that
researchers should standardize their COI methodologies
to improve the consistency and comparability of estimates
[12,13,26]. These studies claim that if two otherwise com-
parable studies have included different components when
estimating a cost of an illness, it would not be meaningful
to compare them. If researchers continue publishing cost
of foodborne illness studies while using different cost in-
ventories (i.e., studies which contain a wide range of com-
ponent costs reported with varying levels of detail), this
trend of insular estimates with limited comparability will
continue. Therefore, the research community engaging in
COI studies may benefit from a discussion of minimum
criteria for component cost and data source reporting.
This scoping review illustrates the breadth of published
cost inventories in the cost of foodborne illness literature
and the depth to which they have been reported. By using
this scoping review as evidence that there is a lack of
standardization in cost inventories in the cost of food-
borne illness literature, and to promote greater transpar-
ency and detail of data source reporting, there will be an
increase in cost of foodborne illness research that can be
interpreted and compared in a meaningful way.
During the literature search, a formal search of the
grey (unpublished) literature was not conducted. How-
ever, the peer-reviewed filter was left unchecked during
the AGRICOLA database search and relevant grey litera-
ture identified at this stage was included in the review.
Also, by only searching a single animal health-related
database (i.e., AGRICOLA), the number of studies iden-
tified as describing the cost of foodborne and infectious
illnesses in animals may be an underestimation. How-
ever, we do not believe that this has biased the results,
as the study reported herein focused on costs related to
foodborne illnesses in humans only. Non-English lan-
guage papers were excluded from the present study, and
therefore, these results may only be applicable to English
speaking countries. Lastly, an optional stage (step 6) in
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is to involve potential end-users in the scoping review
process. Although a consultation was not conducted per
se, members of the research team, who are also end-
users of the information, were directly involved in the
identification of the research question and in outlining
the goals of the review.
Conclusions
Individual and societal level costs have been included in
a substantial number of foodborne illness cost estimates,
indicating that many studies are using cost inventories
that estimate a variety of types of costs. The depth and
breadth of individual and societal level cost inventories
in the cost of foodborne illness literature were highly
variable. This scoping review can be used as evidence
that there is a lack of standardization in cost inventories
in the cost of foodborne illness literature, and to promote
greater transparency and detail of data source reporting. It
should be noted that certain costs may be pathogen spe-
cific and the results of the present study should be inter-
preted with that in mind. Lastly, the results illustrate that
there are a wide variety of data sources available to esti-
mate component costs of foodborne illness. Efforts should
be made to select credible and current sources when de-
termining the costs associated with foodborne illness, and
to report the specific source of data for each component
cost estimate. These suggestions will help address the
issues of uniformity in component cost selection and
reporting. By conforming to a more standardized cost
inventory for cost of foodborne illness studies, and by
reporting data sources in more detail, there will be an
increase in cost of foodborne illness research that can
be interpreted and compared in a meaningful way.
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